Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

180
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
180

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-scale data improves performance of machine learning model for long COVID identification.

Communications medicine·2026
Same author

Landscape of Gene Essentiality in Cancer Cell Death Pathways.

Genes·2026
Same author

Maternal and Pediatric Precision in Therapeutic Knowledge Portal (MPRINT-KP): Landscape Analysis of Pharmacology Research in Maternal and Pediatric Patient Populations.

Pharmacotherapy·2026
Same author

Mechanistic insights into phenolic compounds removal in constructed wetlands: efficiency comparison, synergistic interactions, and future optimization.

Bioresource technology·2026
Same author

The Unique Roles of Microbial Abundant and Rare Taxa in Regulating Pathogen Dynamics in Wastewater Bioaerosols.

Microorganisms·2026
Same author

CRISPR-Cas9 Genome and Double-Knockout Screening to Identify Novel Therapeutic Targets for Chemoresistance in Triple-Negative Breast Cancer.

Cancers·2025
Same journal

Another 10 years of PLOS Computational Biology: A data-driven reflection on trends in genomics research.

PLoS computational biology·2026
Same journal

Mobility data resolution needed to inform predictive models of spatial epidemic spread from mobile phone data.

PLoS computational biology·2026
Same journal

DeepMethylation: A deep learning framework for tissue-specific DNA methylation prediction and functional variant annotation.

PLoS computational biology·2026
Same journal

Redefining and estimating the early-phase reproduction ratio for epidemic outbreaks in spatially structured populations.

PLoS computational biology·2026
Same journal

Optimized phenotype definitions boost GWAS power.

PLoS computational biology·2026
Same journal

Detection, communication, and individual identification with deep audio embeddings: A case study with North Atlantic right whales.

PLoS computational biology·2026
See all related articles

Related Experiment Video

Updated: Aug 31, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

419

DSCN: Double-target selection guided by CRISPR screening and network.

Enze Liu1,2,3, Xue Wu2, Lei Wang2

  • 1Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, Indiana, United States of America.

Plos Computational Biology
|August 19, 2022
PubMed
Summary
This summary is machine-generated.

Developing effective cancer therapies requires identifying optimal gene target combinations. The new DSCN computational method efficiently predicts these combinations by integrating CRISPR screening data with patient gene expression and protein-protein interaction networks.

More Related Videos

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

835
Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
11:35

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Published on: June 16, 2017

12.7K

Related Experiment Videos

Last Updated: Aug 31, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

419
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

835
Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
11:35

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Published on: June 16, 2017

12.7K

Area of Science:

  • Computational Biology
  • Genomics
  • Cancer Research

Background:

  • Cancer is a complex disease driven by multiple mechanisms, necessitating combination therapies for effective treatment.
  • Predicting synergistic gene target combinations is challenging, limiting the development of novel cancer therapies.
  • Current genome-wide screening methods are limited in identifying effective target combinations.

Purpose of the Study:

  • To develop an effective computational approach for selecting candidate gene target combinations for cancer therapy.
  • To ensure translational relevance of predicted target combinations between cell lines and cancer patients.
  • To improve the prediction accuracy and computational efficiency of identifying synergistic gene pairs.

Main Methods:

  • Developed DSCN (double-target selection guided by CRISPR screening and network), a method integrating gene expression, CRISPR screening, and protein-protein interaction (PPI) networks.
  • Utilized a sub-sampling approach to model gene knockdown effects on the PPI network and facilitate second target selection.
  • Employed a 'diffusion-path' scoring scheme to differentiate synthetic lethal (SL) gene pairs and evaluated performance against existing algorithms.

Main Results:

  • The DSCN sub-sampling model showed a high correlation (R2 = 0.75) with observed gene expression changes in pancreatic cell lines after MAP2K1/MAP2K2 inhibition.
  • The 'diffusion-path' method significantly identified known SL gene pairs in pancreatic cancer (P = 0.001).
  • DSCN demonstrated superior performance and at least ten times faster computational speed compared to OptiCon and VIPER algorithms.
  • DSCNi, a sample-specific application, showed a high correlation between predicted and real synergistic drug combinations (P = 1e-5).

Conclusions:

  • DSCN is a highly effective and efficient computational method for selecting synergistic gene target combinations in cancer.
  • The method facilitates the identification of therapeutically relevant target combinations with translational potential.
  • DSCN offers a significant advancement in computational approaches for precision cancer therapy development.